10.5m shares to go in the buyback. Management is nearly out of price-support ammo. Then we shall see what Mr Market thinks of ALY. Ash
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025